Polio Vaccine Market Share Forecast by 2018-2025: Sanofi, GSK, Bibcol, Serum Institute, Tiantan Biological, IMBCA
The classification of Polio Vaccine includes Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV), and the revenue proportion of Inactivated Polio Vaccine (IPV) in 2016 is about 15.4%, and the proportion is in decreasing trend from 2012 to 2016.
View full press release